Michaelson Capital Partners

Renovare Environmental Inc is a technology services company that specializes in innovative waste management solutions for businesses and municipalities. The company aims to enhance environmental outcomes by offering cost-effective options for both on-site and off-site biological treatment of waste. Through its subsidiaries, BioHiTech America and BioHiTech Europe, Renovare delivers advanced products and services to minimize food waste and optimize disposal processes. Its pioneering on-site aerobic digestion technology integrates waste disposal equipment with cloud-based analytics, providing transparency into waste generation through Machine-to-Machine technology. This combination of technological innovation and data analytics supports organizations in their pursuit of ecological sustainability and contributes to a future with zero waste.

Tecogen is a manufacturer of natural-gas-fueled, engine-driven, combined heat and power products. It aims to reduce energy costs, reduce greenhouse gas emissions, and alleviate congestion on the national power grid. Tecogen’s ultra-efficient products include cogeneration modules, which provide electricity and heat, and chillers, which provide air-conditioning and optional free hot water. Tecogen’s products supply electrical power or mechanical power for cooling, as well as free engine heat that gets recovered and purposefully used at customer facilities. The company was founded in 2000 and is headquartered in Waltham, Massachusetts.

Entelos specializes in predictive biosimulation technologies aimed at improving drug discovery and development processes. With over 15 years of experience, the company provides advanced biosimulation capabilities that enhance efficiency and increase the likelihood of clinical success. Its offerings include mechanism-based mathematical models, virtual patients and populations, and comprehensive biosimulation software. By leveraging in-depth systems biology data models, Entelos enables research and development organizations to conduct highly predictive analyses, ultimately reducing the risks, time, and costs associated with product development in the pharmaceutical, healthcare, nutrition, and consumer markets. This approach assists clients in creating safer and more effective drugs, foods, and consumer products.